KYSE520 Cells
545,10 CAD$*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Renseignements généraux
| Description | The KYSE520 cell line is a human esophageal squamous cell carcinoma (ESCC) model derived from a primary tumor. It is moderately differentiated and has been instrumental in investigating epithelial-mesenchymal plasticity (EMP) in esophageal cancer. KYSE520 cells exhibit heterogeneity, consisting of both epithelial-like (CD44v+) and mesenchymal-like (CD44v−) subpopulations. These two populations are capable of interconversion, reflecting a dynamic EMP process. This property makes KYSE520 an excellent model for studying cancer stem cell traits and chemoresistance mechanisms in ESCC. Genetically, KYSE520 cells display notable epigenetic regulation. The promoter region of the JAM3 gene, a tumor suppressor, is unmethylated in these cells, allowing its expression. JAM3 plays a role in regulating cell proliferation, migration, and invasion through Wnt/β-catenin signaling. The maintenance of JAM3 expression in KYSE520 has been linked to the suppression of aggressive cancer phenotypes. In therapeutic research, KYSE520 cells have been used to explore the role of fibroblast growth factor receptor-like 1 (FGFRL1). Studies have shown that FGFRL1-deficient KYSE520 cells exhibit reduced tumor growth and motility, alongside a decrease in matrix metalloproteinase-1 (MMP-1) and fibroblast growth factor binding protein 1 (FGFBP1) expression. These findings underscore the importance of FGFRL1 in tumorigenesis and suggest potential therapeutic targets. Additionally, the EMP dynamics and associated molecular pathways in KYSE520 cells provide insights into ESCC progression and resistance mechanisms, contributing to the development of targeted treatments. |
|---|---|
| Organisme | Human |
| Tissu | Esophagus |
| Maladie | Squamous cell carcinoma |
| Synonymes | KYSE 520, KYSE-520, Kyse520, KYSE0520 |
Caractéristiques
| Âge | 58 years |
|---|---|
| Genre | Female |
| Origine ethnique | Japanese |
| Morphologie | Epithelial-like |
| Propriétés de croissance | Adherent, monolayer |
Données réglementaires
| Référence | KYSE520 (Cytion catalog number 305449) |
|---|---|
| Niveau de biosécurité | 1 |
| NCBI_Numéro d'identification fiscale | 9606 |
| Cellosaurus - Numéro d'enregistrement | CVCL_1355 |
Données biomoléculaires
| Oncogènes | TP53, MYC |
|---|---|
| Profil mutationnel | Mutation: TP53, c.376-2A>T, Splice acceptor mutation |
Manipulation
| Milieu de culture | Ham's F12, w: 1.0 mM stable Glutamine, w: 1.0 mM Sodium pyruvate, w: 1.1 g/L NaHCO3 (Cytion article number 820600a) + RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a); 1:1 mixture |
|---|---|
| Suppléments | Supplement the medium with 2% FBS |
| Réactif de dissociation | Accutase |
| Repiquage | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Densité de semis | 0.6 - 1.2 x 104 cells/cm2 |
| Renouvellement des fluides | 2 times per week |
| Milieu de congélation | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Décongélation et culture des cellules |
|
| Atmosphère d'incubation | 37°C, 5% CO2, humidified atmosphere. |
| Conditions d'expédition | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Conditions d'entreposage | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Contrôle de la qualité et analyse moléculaire
| Stérilité | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificat d'analyse (CoA)
| Numéro de lot | Type de certificat | Date | Numéro de catalogue |
|---|---|---|---|
| 305449-020125 | Certificat d'analyse | 05. Mar. 2026 | 305449 |
| 305449-170426 | Certificat d'analyse | 15. May. 2026 | 305449 |
-
Related products
Related products
KYSE-150 CellsOrganisme Human Tissu Esophagus Maladie Esophageal squamous cell carcinoma 545,10 CAD$*KYSE-30 CellsOrganisme Human Tissu Esophageal Squamous Epithelium Maladie Esophageal squamous cell carcinoma 545,10 CAD$*KYSE-410 CellsOrganisme Human Tissu Esophagus Maladie Esophageal squamous cell carcinoma 545,10 CAD$*